BNP Paribas Financial Markets’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-47,508
| Closed | -$1.28M | – | 3370 |
|
2022
Q4 | $1.28M | Sell |
47,508
-9,797
| -17% | -$264K | ﹤0.01% | 1460 |
|
2022
Q3 | $1.03M | Buy |
57,305
+30,353
| +113% | +$545K | ﹤0.01% | 1860 |
|
2022
Q2 | $335K | Sell |
26,952
-45,557
| -63% | -$566K | ﹤0.01% | 2253 |
|
2022
Q1 | $966K | Sell |
72,509
-13,870
| -16% | -$185K | ﹤0.01% | 1837 |
|
2021
Q4 | $1.34M | Buy |
86,379
+78,879
| +1,052% | +$1.23M | ﹤0.01% | 1837 |
|
2021
Q3 | $168K | Sell |
7,500
-178
| -2% | -$3.99K | ﹤0.01% | 2518 |
|
2021
Q2 | $175K | Buy |
7,678
+3,907
| +104% | +$89K | ﹤0.01% | 2317 |
|
2021
Q1 | $77.6K | Buy |
3,771
+3,686
| +4,336% | +$75.9K | ﹤0.01% | 2898 |
|
2020
Q4 | $2.35K | Hold |
85
| – | – | ﹤0.01% | 3334 |
|
2020
Q3 | $1.19K | Buy |
+85
| New | +$1.19K | ﹤0.01% | 3450 |
|
2020
Q2 | – | Sell |
-88
| Closed | -$664 | – | 3749 |
|
2020
Q1 | $664 | Sell |
88
-79
| -47% | -$596 | ﹤0.01% | 3519 |
|
2019
Q4 | $2.59K | Buy |
167
+13
| +8% | +$202 | ﹤0.01% | 3538 |
|
2019
Q3 | $801 | Hold |
154
| – | – | ﹤0.01% | 3762 |
|
2019
Q2 | $1.39K | Buy |
154
+93
| +152% | +$842 | ﹤0.01% | 3726 |
|
2019
Q1 | $1.46K | Hold |
61
| – | – | ﹤0.01% | 3538 |
|
2018
Q4 | $1K | Sell |
61
-39
| -39% | -$640 | ﹤0.01% | 3242 |
|
2018
Q3 | $2.66K | Hold |
100
| – | – | ﹤0.01% | 3549 |
|
2018
Q2 | $2.29K | Hold |
100
| – | – | ﹤0.01% | 3583 |
|
2018
Q1 | $2.13K | Buy |
100
+85
| +567% | +$1.81K | ﹤0.01% | 3501 |
|
2017
Q4 | $190 | Hold |
15
| – | – | ﹤0.01% | 3446 |
|
2017
Q3 | $232 | Hold |
15
| – | – | ﹤0.01% | 3477 |
|
2017
Q2 | $176 | Sell |
15
-31
| -67% | -$364 | ﹤0.01% | 3517 |
|
2017
Q1 | $540 | Buy |
+46
| New | +$540 | ﹤0.01% | 3247 |
|